Inventor · disambiguated record
John Landon
Also filed as: LANDON JOHN · LANDON JR JOHN T
9 granted patents·6 pending applications·59 citations·filing 1975–2022
86Inventor score
Files withMICROPHARM LTD4SHONE CLIFFORD3SEC DEP FOR HEALTH AND SOCIAL CARE2THE SEC DEP FOR HEALTH2EASTMAN KODAK CO1
Top patents by PatentIndex Score
15 records- 0190US8921529B2Therapies for preventing or suppressing Clostridium difficile infectionSHONE CLIFFORD·Filed 2010·Granted Dec 30, 2014·15 cites·16 claims
- 0276US8709428B2Antibodies to Clostridium difficile toxinsSHONE CLIFFORD·Filed 2010·Granted Apr 29, 2014·2 cites·6 claims
- 0375US12491239B2Clostridium difficile antigensSEC DEP FOR HEALTH AND SOCIAL CARE·Filed 2022·Granted Dec 9, 2025·0 cites·1 claims
- 0471US10369206B2Clostridium difficile antigensSHONE CLIFFORD·Filed 2011·Granted Aug 6, 2019·2 cites·7 claims
- 0567US2021369830A1Clostridium difficile antigensSEC DEP FOR HEALTH AND SOCIAL CARE·Filed 2021·Application pending·0 cites
- 0665US4013470AWarm image tone providing photographic elementEASTMAN KODAK CO·Filed 1975·Granted Mar 22, 1977·8 cites·16 claims
- 0764US5733742AProduction of antibody fragments from whole bloodTHERAPEUTIC ANTIBODIES INC·Filed 1994·Granted Mar 31, 1998·20 cites·9 claims
- 0858US2019328859A1Clostridium difficile antigensTHE SEC DEP FOR HEALTH·Filed 2019·Application pending·0 cites
- 0954US6193969B1Antibody fragments in therapyPROTHERICS INC·Filed 1994·Granted Feb 27, 2001·12 cites·14 claims
- 1050US11098114B2Ovine derived human TNFα polyclonal antibody composition for oral administrationMICROPHARM LTD·Filed 2018·Granted Aug 24, 2021·0 cites·13 claims
- 1149US2015010580A1Antibodies to clostridium difficile toxinsSHONE CLIFFORD CHARLES·Filed 2014·Application pending·0 cites
- 1248US2021347876A1Therapies for treating inflammatory disordersMICROPHARM LTD·Filed 2021·Application pending·0 cites
- 1342US10519219B2Filovirus therapyTHE SEC DEP FOR HEALTH·Filed 2016·Granted Dec 31, 2019·0 cites·19 claims
- 1437US2021301008A1Therapies for treating oral mucositis with polyclonal anti-tnfalpha antibodiesMICROPHARM LTD·Filed 2019·Application pending·0 cites
- 1530US2021292403A1Therapies for treating proctitis with polyclonal anti-tnfalpha antibodiesMICROPHARM LTD·Filed 2019·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when John Landon files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →